Article info

Download PDFPDF
Extended report
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon
  1. Correspondence to David L Boyle, Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, 9500 Gilman Drive, La Jolla, CA 92093-0656, USA; dboyle{at}ucsd.edu
View Full Text

Citation

Rosengren S, Corr M, Firestein GS, et al
The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon

Publication history

  • Received February 11, 2011
  • Accepted August 27, 2011
  • First published November 25, 2011.
Online issue publication 
February 06, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.